Turning patient experience into evidence that drives better decisions

Reservoir Health helps organizations generate, apply patient-centered evidence using fit-for-purpose methods tailored to the decisions the evidence is intended to inform. Our work spans early strategy and evidence through regulatory, HTA, payer, clinical development, market access, and AI-enabled decision-making

Health care decision-makers increasingly expect evidence that demonstrates not only whether a therapy works, but how it affects patients' lives and performs in real-world practice.

Patient insights and evidence support a wide range of decisions, from understanding unmet need and informing product strategy to guiding clinical development, market access, reimbursement, and policy. Different decisions require different types of evidence, making it essential to match the methodology to the question being asked.

The Reservoir approach

Reservoir Health helps clients generate, strengthen, synthesize and apply patient evidence across the product lifecycle. We use fit-for-purpose methods tailored to the decisions the evidence is intended to inform, spanning evidence planning and gap assessment, primary research, evidence synthesis, patient-centered real-world evidence, endpoint strategy, provider adoption research, payer engagement, and dissemination – including the development of rigorous, regulatory-grade patient experience data.

This work is led by internationally recognized experts in patient-centered evidence generation and, patient-focused drug development,. Many of their studies are subsequently published in peer-reviewed journals and presented at leading scientific conferences. Their expertise is strengthened by Reservoir’s broader capabilities in policy, market access, and communications, helping organizations move beyond isolated patient studies and build and execute integrated evidence strategies.

Patient Evidence Leadership

Reservoir’s Patient Evidence practice advances patient-focused evidence by generating data that reflects the outcomes and treatment impacts that matter most to patients. Using fit-for-purpose methods, we help organizations integrate the patient perspective into regulatory strategy, clinical development, health technology assessment, reimbursement, market access, and policy decisions.

Ourexpertise

Patient experience, burden of disease, and access evidence

Understanding how patients experience disease is fundamental to demonstrating therapeutic value. We generate and synthesize evidence on disease burden, unmet need, treatment experience, patient preferences, and access barriers, helping organizations build a patient-centered evidence base that informs development strategy, value demonstration,market access, and healthcare decision making.

Clinical outcome assessment and endpoint strategy

We identify the symptoms, functional impacts, and treatment benefits that matter most to patients and translate those insights into fit-for-purpose outcome measurement strategies. Our work includes conceptual model development, clinical outcome assessment (COA) strategy, endpoint selection and evaluation, patient-reported outcome (PRO) strategy, qualitative research, exit interviews, and regulatory evidence planning to help ensure clinical studies measure outcomes that are meaningful to patients.

Patient-centered real-world evidence

Real-world evidence is most valuable when it reflects not only what happened, but what it meant to patients. We combine patient experience research with real-world data, patient-reported outcomes, registries, surveys, and other data sources to generate evidence that better reflects treatment effectiveness and patient outcomes in routine clinical practice.

Provider adoption and care delivery research

Successful adoption depends on how therapies fit into clinical practice. Using ethnographic research, workflow analysis,
journey mapping, and in-depth qualitative methods, we identify barriers and facilitators to implementation, informing launch strategy, patient support programs, and health care delivery.

Where patient evidence is most useful

Regulatory and patient-focused drug development strategy

HTA, payer, value, and market access planning

Clinical outcome assessment and endpoint planning

Real-world evidence and patient-reported outcomes strategy

Launch planning, provider adoption, and care delivery research

AI-enabled evidence ecosystems and payer decision-making workflows